Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02818114 · ClinicalTrials.gov registry record · NA
Peer Enhanced Prolonged Exposure
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT02818114: Completed NA study, sponsored by VA Office of Research and Development.
NCT02818114 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02818114, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The investigators plan to develop and test an intervention using peer specialists (Veterans who have managed PTSD and completed PE) to provide support services for Veterans using prolonged exposure therapy.
Primary Outcome
Number of PE Sessions attended during 10 weeks of participation in study. 10 is the maximum, 0 is the minimum. Higher numbers of sessions attended are an indication of better engagement in treatment.
Interventions
- BEHAVIORAL Peer Enhanced Prolonged Exposure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2016-10-16 |
| Est. Completion | 2018-10-30 |
| Phase | NA |
What the finished NCT02818114 record still lists
NCT02818114 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Peer Enhanced Prolonged Exposure is the first listed.
NCT02818114 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02818114 about?
NCT02818114 is a clinical study titled "Peer Enhanced Prolonged Exposure". The investigators plan to develop and test an intervention using peer specialists (Veterans who have managed PTSD and completed PE) to provide support services for Veterans using prolonged exposure therapy.
What is the current status of trial NCT02818114?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2016-10-16. Estimated completion is 2018-10-30.
What interventions are being tested in trial NCT02818114?
The interventions under investigation include: Peer Enhanced Prolonged Exposure (BEHAVIORAL).
Who is sponsoring clinical trial NCT02818114?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02818114's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI